Geode Capital Management, LLC Harrow Health, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 810,803 shares of HROW stock, worth $27.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

810,803

Previous 774,079 4.74%

Holding current value

$27.9 Million

Previous $20.6 Million 20.26%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$22.2 - $31.61 $815,272 - $1.16 Million	36,724 Added 4.74%	810,803 $24.8 Million
Q1 2025 May 13, 2025	BUY	$22.22 - $36.67 $1.18 Million - $1.94 Million	52,971 Added 7.35%	774,079 $20.6 Million
Q4 2024 Feb 12, 2025	SELL	$33.39 - $57.5 $54,158 - $93,265	-1,622 Reduced 0.22%	721,108 $24.2 Million
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $82,566 - $184,021	3,960 Added 0.55%	722,730 $32.5 Million
Q2 2024 Aug 09, 2024	BUY	$10.0 - $21.64 $247,910 - $536,477	24,791 Added 3.57%	718,770 $15 Million
Q1 2024 May 13, 2024	BUY	$9.3 - $13.23 $208,626 - $296,788	22,433 Added 3.34%	693,979 $9.18 Million
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $445,038 - $898,867	54,943 Added 8.91%	671,546 $7.52 Million
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $1.02 Million - $1.6 Million	72,482 Added 13.32%	616,603 $8.86 Million
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $4.8 Million - $7.77 Million	276,586 Added 103.38%	544,121 $10.4 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $324,631 - $503,365	23,456 Added 9.61%	267,535 $5.66 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $120,718 - $173,561	11,743 Added 5.05%	244,079 $3.6 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $2,936 - $11,121	447 Added 0.19%	232,336 $2.8 Million
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.74 $12,362 - $16,641	2,150 Added 0.94%	231,889 $1.69 Million
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $765 - $978	-113 Reduced 0.05%	229,739 $1.57 Million
Q3 2021 Nov 12, 2021	BUY	$6.99 - $10.6 $81,328 - $123,331	11,635 Added 5.33%	229,852 $2.09 Million
Q2 2021 Aug 13, 2021	SELL	$6.68 - $11.07 $1.05 Million - $1.74 Million	-157,218 Reduced 41.88%	218,217 $2.03 Million
Q1 2021 May 12, 2021	BUY	$6.26 - $11.03 $196,770 - $346,705	31,433 Added 9.14%	375,435 $2.53 Million
Q4 2020 Feb 12, 2021	BUY	$4.76 - $6.93 $54,045 - $78,683	11,354 Added 3.41%	344,002 $2.36 Million
Q3 2020 Nov 13, 2020	BUY	$4.71 - $7.36 $21,279 - $33,252	4,518 Added 1.38%	332,648 $1.86 Million
Q2 2020 Aug 13, 2020	BUY	$3.61 - $6.47 $512,042 - $917,704	141,840 Added 76.14%	328,130 $1.71 Million
Q1 2020 May 14, 2020	SELL	$3.5 - $7.31 $33,908 - $70,819	-9,688 Reduced 4.94%	186,290 $711,000
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $50,803 - $105,235	12,096 Added 6.58%	195,978 $1.71 Million
Q1 2019 May 14, 2019	BUY	$4.75 - $7.1 $873,439 - $1.31 Million	183,882 New	183,882 $915,000

Others Institutions Holding HROW

# of Institutions

181

Shares Held

21.4M

Call Options Held

330K

Put Options Held

670K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $932M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Harrow Health, Inc. Transaction History